Taiwan import license bolsters George Clinical's abilities in Asia-Pacific

By Maggie Lynch

- Last updated on GMT

(Image: Getty/bedo)
(Image: Getty/bedo)
George Clinical receives license to import clinical trial supply into Taiwan as the Asia-Pacific region continues to develop as a clinical trial site.

The global contract research organization (CRO), which is based in Sydney with offices in Hong Kong, Beijing, Shanghai and Bengaluru, was granted a license to import drugs into Taiwan on behalf of sponsors for clinical trials.

This license will enable George Clinical to provide import services to small and mid-sized clinical trial clients who do not have an entity in Taiwan, as it would otherwise and previously rely on large individual pharmaceutical companies to import on its behalf.

George Clinical stated that with this license in Taiwan it can now serve as a one-stop-shop provider for sponsors looking to expand into Taiwan for trials. Before this license, George Clinical was only able to provide project and site management to its clients instead of drug management.

Additionally, George Clinical now offers drug importation for renewals and amendments, investigational medicinal product (IMP) stock management, closure and inspection after clinical study report submission, re-labeling, return and destruction.

Taiwan, and the Asia-Pacific region are growing as clinical trial locations. The region has a large and diverse patient population​, CROs like Premier Research and PSI CRO​ have both expanded into Taiwan within the last two years.

Premier Research’s VP and head of Asia Pacific, Ashish Jain, previously told us that economic growth​ in the region and greater patient access to new drugs has led to an amplified demand for clinical trials. PSI CRO’s head of corporate development also told us that the country has become an important contributor to global clinical trials after it opened an office in Taipei in 2017. 

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us

Products

View more

Webinars